4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-19-041173
Chief Medical Officer gave up 1,648 shares (to pay taxes)
- Chief Medical Officer acquired 6,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gordon David N. Chief Medical Officer | 2019-07-02 | Option exercise | +6,000 | 6,000 | D | ||
| Gordon David N. Chief Medical Officer | 2019-07-02 | Shares withheld for taxes | −1,648 | $2.34 | $3,856 | 4,352 | D |
| Derivatives | |||||||
| Gordon David N. Chief Medical Officer | 2019-07-02 | Option exercise · Restricted Stock Units | −6,000 | 18,000 | D | ||
Loading xslF345X03/doc4.xml…